Year: 2019

FDA Fast Tracks RRMM Drug for Potential Combination Therapy

This week, the United States Food and Drug Administration gave Kayropharm Therapeutics accelerated approval for its oral therapy drug selinexor (Xpovio), to be used with the corticosteroid dexamethasone as a combination therapy for adults with relapsed/refractory multiple myeloma (RRMM) and have run out of treatment options.  Relapsed/refractory multiple myeloma is

Common Kitchen Sponge Viruses May Consume Tough Bacteria

New research presented this weekend at the annual American Society for Microbiology suggests that some viruses—which often populate kitchen sponges—are able to eat bacteria.   Of course, a kitchen sponge is consistently exposed to myriad microbes, which means that they each develop their own special microbiome of organisms, and particularly bacteria.  And,

Bristol-Myers Still Waiting For FTC Approval of Celgene Takeover

Shares of Bristol-Myers Squibb took a big dip to start the week after the group announced the US Federal Trade Commission (FTC) is still examining their proposed $74 billion acquisition of cancer specialist Celgene Corporation.  Offering to sell the company’s psoriasis business to move the deal forward, the FTC’s hesitancy seemed

If you use ‘God ‘or ‘Pray’ in your Facebook posts, study says you could end up with life-threatening condition. Seriously?

Raina Merchant, the lead author of the study and the director of Penn Medicine’s Center for Digital Health, and her team of researchers in conjunction with researchers from Stony Brook University(The State University of New York) report in Penn Medicine News that language in Facebook posts may give early identification to